2th Annual Pharma & Biotech Licensing & Deal Making Summit
12/10/2007
The cost of Pharmaceutical and Biotechnology deals exceeded multi-billion dollars in the first half of 2007. The business development function has never seen more action, as the industry continues to be driven by ever-changing dynamics, pipeline concerns, and fast-growing biotech productivity and profitability.
It has never been more urgent than now to fuel new growth. We invite you to join us for two unique conferences, held in one place at one time.
Join us for an analysis of deal making trends and market impact, as well as future deal making outlook, at home and abroad. Find out where the new deals are taking place, what factors drive them forward, and what it takes to close the deal.
This 2-in-1 conference offers you the best opportunity to meet prospective partners and gather a wealth of new industry information. That’s what has distinguished the series over its many years- quality information, high-level networking and lots of the right people!
